Company Overview of Neocrin Company
As of August 1999, Neocrin Company was acquired by Novocell, Inc. Neocrin Company researches and develops minimally invasive, encapsulated cellular transplants for the treatment of diabetes. Neocrin's technology consists of proprietary immunoprotective cell encapsulation materials and cell purification techniques that the company believes will make it possible to inject insulin-producing, porcine-derived pancreatic cells (islets) into the peritoneal cavity without chronic immunosuppression, to provide near-normal blood glucose control by naturally regulating insulin release. Neocrin Company was founded by Mr. Wes Farrell in 1992. It is headquartered in Irvine, California.
31 Technology Drive
Irvine, CA 92618
Founded in 1992
Key Executives for Neocrin Company
Neocrin Company does not have any Key Executives recorded.
Similar Private Companies By Industry
|OxoN Medica, Inc.||United States|
|Berkeley Advanced Biomaterials, Inc.||United States|
|Parenta Pharmaceuticals, Inc.||United States|
|MeriCal, Inc.||United States|
|Medinox, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Neocrin Company, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.